Quest PharmaTech Inc. reported earnings results for the third quarter and nine months ended October 31, 2021. For the third quarter, the company reported net loss was CAD 9.03 million compared to net income of CAD 3.78 million a year ago. Basic loss per share from continuing operations was CAD 0.054 compared to basic earnings per share from continuing operations of CAD 0.023 a year ago. Diluted loss per share from continuing operations was CAD 0.054 compared to diluted earnings per share from continuing operations of CAD 0.022 a year ago. For the nine months, net loss was CAD 9.17 million compared to net income of CAD 113.03 million a year ago. Basic loss per share from continuing operations was CAD 0.055 compared to basic earnings per share from continuing operations of CAD 0.674 a year ago. Diluted loss per share from continuing operations was CAD 0.055 compared to diluted earnings per share from continuing operations of CAD 0.663 a year ago.